                         SEQUENCE LISTING

<110>  NEXTAR CHEMPHARMA SOLUTIONS LTD
 
<120>  DRUG CONTAINING TARGETING LIPOSOMES

<130>  NEXT 3241-1-2

<150>  US 62/894,794
<151>  2019-09-01

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Optionally M is oxidized or methionine sulfoxide

<400>  1

Ala His Arg Glu Arg Met Ser 
1               5           


